Quoin Pharmaceuticals, Ltd. (QNRX) Financials
QNRX Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 12.2 million | 6.5 million |
2023-09-30 | 15.1 million | 7.7 million |
2023-06-30 | 16.7 million | 7.6 million |
2023-03-31 | 18.5 million | 7.5 million |
QNRX Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | -3.3 million | 300198 |
2023-09-30 | -1.3 million | 268503 |
2023-06-30 | -1.6 million | 264376 |
2023-03-31 | -1.7 million | 261472 |
QNRX Net Income
No data available :(
QNRX Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 10.7 million | - | - |
2023-09-30 | 14.0 million | - | - |
2023-06-30 | 15.4 million | - | - |
2023-03-31 | 17.0 million | - | - |
QNRX Shares Outstanding
QNRX Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | - | 815460 | 1.4 million | - |
2023-09-30 | - | 758759 | 1.4 million | - |
2023-06-30 | - | 625104 | 1.6 million | - |
2023-03-31 | - | 1.1 million | 1.7 million | - |
QNRX Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | - | 25952 |
2023-09-30 | - | 25915 |
2023-06-30 | - | 25705 |
2023-03-31 | - | 25767 |
QNRX
Price: $0.71
52 week price:
Earnings Per Share: -9.64 USD
P/E Ratio: 2.43
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 102500
Market Capitalization: 3.2 million